CLINICAL_TRIALS
trial_result
· 2012-08-17
Clinical Trial Update: Safety Study of F2695 SR in Major Depressive Disorder [Phase 3]
Summary
A Phase 3 safety study of F2695 SR in adults with Major depressive disorder has completed; the snippet does not include the trial results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED